Highlights Cisen Pharmaceutical Co., Ltd.

Equities

603367

CNE100002VG4

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
16.34 ^CNY	+0.25%		-5.22%	+11.61%

23/04	Cisen Pharmaceutical Names Chief Financial Officer	MT
22/04	Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04	CI
Cisen Pharmaceutical Scraps Unit Spin-Off Plan	01/12	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Cisen Pharmaceutical to Spin Off Unit for Shenzhen Float	09/23/09	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
Cisen Pharmaceutical Secures Regulatory Approval for Methylcobalamin Tablets	22/22/22	MT
Cisen Pharmaceutical Gets Regulatory Approval for Registration of Two Drugs	17/22/17	MT
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	17/22/17	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22/22/22	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/22/26	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25	CI
Shijiazhuang No.4 Pharmaceutical Co., Ltd. completed the acquisition of 6.1% stake in Cisen Pharmaceutical Co., Ltd. from Wu Hengke.	31/21/31	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/21/26	CI
Sichuan Kelun Pharmaceutical Co., Ltd. completed the acquisition of 10% stake in Cisen Pharmaceutical Co., Ltd. from Tianjin Qianding Enterprise Management Partnership (Limited Partnership).	14/21/14	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	18/21/18	CI
Shijiazhuang No.4 Pharmaceutical Co., Ltd. entered into an agreement to acquire 6.1% stake in Cisen Pharmaceutical Co., Ltd. from Wu Hengke for approximately CNY 350 million.	29/21/29	CI
Sichuan Kelun Pharmaceutical Co., Ltd. agreed to acquire 10% stake in Cisen Pharmaceutical Co., Ltd. from Tianjin Qianding Enterprise Management Partnership (Limited Partnership) for approximately CNY 580 million.	28/21/28	CI
Cisen Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	28/21/28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cisen Pharmaceutical Co., Ltd.

Equities

603367

CNE100002VG4

Highlights

Filters